Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Becton Dickinson (NY: BDX )

228.47 +1.26 (+0.55%)
Streaming Delayed Price Updated: 12:17 PM EST, Feb 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,226,999
Open 229.15
Bid (Size) 228.46 (1)
Ask (Size) 228.65 (6)
Prev. Close 227.21
Today's Range 226.55 - 229.62
52wk Range 218.75 - 251.99
Shares Outstanding 287,190,180
Dividend Yield 1.66%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Becton Dickinson Q1 Earnings: Revenue And EPS Beat, Lowers Outlook, Outlines Intent To Separate Biosciences And Diagnostic Solutions Business
Becton Dickinson plans to spin off its Biosciences and Diagnostic Solutions unit, targeting a fiscal 2026 completion, while updating FY25 revenue guidance. 
Via Benzinga
BD (BDX) To Report Earnings Tomorrow: Here Is What To Expect
Medical technology company Becton, Dickinson and Company (NYSE:BDX) will be announcing earnings results tomorrow before market open. Here’s what to look for. 
Via StockStory

Performance

YTD
+0.87%
+0.87%
1 Month
-1.59%
-1.59%
3 Month
+0.60%
+0.60%
6 Month
-2.53%
-2.53%
1 Year
-4.60%
-4.60%

More News

Read More
Activist Starboard Value Pushes Becton Dickinson To Divest Life Sciences Unit
Via Benzinga
Biotech And Healthcare Stocks Poised For Gains Ahead
Via Talk Markets
Topics ETFs Stocks / Equities
5 S&P 500 Stocks Set To Shine In The Final Week Of January — If History Repeats Itself
Via Benzinga
Topics Artificial Intelligence Government Stocks
Exposures Artificial Intelligence Political US Equities
Price Over Earnings Overview: Becton Dickinson
Via Benzinga
(BDX) - Analyzing Becton Dickinson's Short Interest
Via Benzinga
(BDX) - Analyzing Becton Dickinson's Short Interest
Via Benzinga
BD and Biosero Collaborate to Enable Robotic Integration with Flow Cytometers Used in Drug Discovery and Development
From Biosero, Inc.
Via Business Wire
5 Stocks to Sell Before Trump's Mexico Tariffs
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
Two Big Weeks To Play A Rally In Biotech And Healthcare Stocks
Via Talk Markets
Topics ETFs Stocks / Equities
10 Buy And Hold Forever Dividend Stocks
Via Talk Markets
Topics Stocks / Equities
Price Over Earnings Overview: Becton Dickinson
Via Benzinga
A Glimpse Into The Expert Outlook On Becton Dickinson Through 4 Analysts
Via Benzinga
(BDX) - Analyzing Becton Dickinson's Short Interest
Via Benzinga
Financial Crime Weekly: Becton, Dickinson And Co. Pays $175 Million Penalty, Express Fails To Disclose CEO's Full Compensation
Via Benzinga
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
13 Healthcare Sector Stocks With Healthy Valuation
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities
Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps
Via Benzinga
Jim Cramer Says This Tobacco Stock Is 'Undervalued' But He's Not Recommending It
Via Benzinga
Wall Street Closes At Record Highs After Reassurance From Powell: Magnificent 7 Hit $17 Trillion, Treasury Yields Erase Post-Election Spike
Via Benzinga
Global Medical Tech Becton, Dickinson Expects Lower China Sales, Bioscience And Pharma Market Dynamics To Impact 2025 Organic Revenue Growth
Via Benzinga
Medtronic Inc. Dividend Stock Analysis - Sunday, Sept. 29
Via Talk Markets
Top Analyst Reports For Nvidia, American Express & Wells Fargo
Via Talk Markets
The 3 Best Dividend Aristocrats to Buy for Sustainable Income: August 2024
Via InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.